about
Potential impact of benzodiazepine use on the rate of hip fractures in five large European countries and the United StatesCase-control study of regular analgesic and nonsteroidal anti-inflammatory use and end-stage renal diseaseSynergism between prior Anisakis simplex infections and intake of NSAIDs, on the risk of upper digestive bleeding: a case-control studyUtilisation and off-label prescriptions of respiratory drugs in childrenSystematic Review and Meta-Analysis: Macrolides- and Amoxicillin/Clavulanate-induced Acute Liver Injury.Sources of European drug consumption data at a country level.Inpatient drug utilization in Europe: nationwide data sources and a review of publications on a selected group of medicines (PROTECT project).A compilation of research working groups on drug utilisation across Europe.Selective serotonin reuptake inhibitors and gastrointestinal bleeding: a case-control study.Paracetamol in therapeutic dosages and acute liver injury: causality assessment in a prospective case series.Upper gastrointestinal bleeding associated with the use of NSAIDs: newer versus older agents.Prescribing of long-acting beta-2-agonists/inhaled corticosteroids after the SMART trialSales of macrolides, lincosamides, streptogramins, and amoxicillin/clavulanate in the in- and outpatient setting in 10 European countries, 2007-2010.Tiotropium Respimat(®) vs. HandiHaler(®): real-life usage and TIOSPIR trial generalizability.Antiepileptic drugs and suicide: a systematic review of adverse effects.Inhaled beta-2-agonists/muscarinic antagonists and acute myocardial infarction in COPD patients.Genetic variants associated with antithyroid drug-induced agranulocytosis: a genome-wide association study in a European population.Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study.A new risk of bias checklist applicable to randomized trials, observational studies, and systematic reviews was developed and validated to be used for systematic reviews focusing on drug adverse events.Multi-centre, multi-database studies with common protocols: lessons learnt from the IMI PROTECT project.Sulfasalazine-induced agranulocytosis is associated with the human leukocyte antigen locus.Fatal aplastic anaemia associated with nifedipine.Bradycardia after rapid intravenous infusin of amphotericin B.Prevalence of CYP2C9 polymorphisms in the south of Europe.Epidemiology of aplastic anemia: a prospective multicenter studyProton Pump Inhibitors and Risk of Upper Gastrointestinal Bleeding in NSAID UsersUse of granulocyte colony-stimulating factor (G-CSF) and outcome in patients with non-chemotherapy agranulocytosisRisk of acute liver injury associated with the use of drugs: a multicentre population surveyDrug prescribing and use among elderly people in SpainStudy of antidepressant use in 5 European settings. Could economic, sociodemographic and cultural determinants be related to their use?Incidence of direct oral anticoagulant use in patients with nonvalvular atrial fibrillation and characteristics of users in 6 European countries (2008-2015): A cross-national drug utilization study
P50
Q24598759-7B7CE1F4-5980-4409-B516-EEF4B615D39CQ28175145-5902846D-B4BB-4C5A-A1BC-083CF379120FQ28478839-8992B7EC-92EC-4877-AA6C-A6C2FEB0B81CQ28542692-40DDEF27-4237-4E18-9B32-FABDF340B9A8Q30251991-FB4D4593-2565-4A0D-BFD5-99570C17DC6FQ30827537-6D640C65-4D21-4FB0-B127-4F4B9294DD91Q30871526-76021AE1-4F1B-45CF-9BAF-F703492FE341Q33559405-05BFCB6A-3E27-4ACF-B179-81143C912571Q33916845-F2133B56-0F22-414C-8853-C50FE600AC13Q33962491-AE3CAFD6-0423-427C-A82D-690494ADE9D3Q34320858-1CDE3368-3E9F-42B5-9926-B611FADFEB33Q35595713-F5A3ED2B-DC9B-42A2-AEC6-C56B9F018144Q36234497-0ADF436B-6432-4FEF-89B9-997D7B0C9F11Q36802125-E3EA4506-A634-4441-B794-AC39F3D89169Q38176728-CDFC4339-CCC7-48AA-BA9B-2B139887F51CQ38221997-E8F53523-4B4B-4D7B-A335-A216BAA8678FQ38869948-1CBCC540-C81E-42D1-A7BA-B4D876C18E56Q39043874-D904BC31-4E59-474B-AAFE-A54421F53AC4Q39294149-BBE89C52-F472-4A62-A40C-C9EA3617E37BQ39869491-3E1334AE-3628-466D-B0B1-074375FE008DQ40099981-E757F71C-37CF-4D7D-B3EA-F662F56F90BFQ42539563-C65E385F-A248-4EE5-8615-C360378280FAQ42562330-6FA438F6-F58D-4B76-B391-04A07EC5697AQ46043535-67095259-669F-464C-BCB8-FC01C8E86CE4Q58863924-26A4E2C9-6071-42E7-93D5-CE0D6D15C6A6Q58863925-4D83AB87-C3C1-47DB-B2C4-A64A28A8CD50Q58863927-93F2F828-8882-4045-BD56-CB0A834799D0Q58863929-C4A0D81D-A9D7-4A7E-976D-2E53375BBAEAQ71762471-0B645AB8-FDB2-4ACE-987F-67952FFCB397Q91739143-F328F44B-38D1-41A0-8E7B-81C5EB5499C1Q91983328-AFE7744A-2067-4053-9E85-2483E5FED4CB
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Luisa Ibáñez
@ast
Luisa Ibáñez
@en
Luisa Ibáñez
@es
Luisa Ibáñez
@nl
type
label
Luisa Ibáñez
@ast
Luisa Ibáñez
@en
Luisa Ibáñez
@es
Luisa Ibáñez
@nl
prefLabel
Luisa Ibáñez
@ast
Luisa Ibáñez
@en
Luisa Ibáñez
@es
Luisa Ibáñez
@nl
P1053
M-2986-2013
P106
P1153
7102108117
P21
P31
P496
0000-0002-1175-0574